Operating Margin of ImmunityBio, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
ImmunityBio, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • ImmunityBio, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -316%, a 94% increase year-over-year.
  • ImmunityBio, Inc. annual Operating Margin for 2024 was -2334%, a 96% increase from 2023.
  • ImmunityBio, Inc. annual Operating Margin for 2023 was -58240%, a 60% increase from 2022.
  • ImmunityBio, Inc. annual Operating Margin for 2022 was -146374%, a 314% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

ImmunityBio, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -316% +4596% +94% 01 Jul 2025 30 Sep 2025
Q2 2025 -504% +27023% +98% 01 Apr 2025 30 Jun 2025
Q1 2025 -1004% +113521% +99% 01 Jan 2025 31 Mar 2025
Q4 2024 -2334% +55905% +96% 01 Oct 2024 31 Dec 2024
Q3 2024 -4912% +60153% +92% 01 Jul 2024 30 Sep 2024
Q2 2024 -27527% +35383% +56% 01 Apr 2024 30 Jun 2024
Q1 2024 -114525% -51913% -83% 01 Jan 2024 31 Mar 2024
Q4 2023 -58240% +88135% +60% 01 Oct 2023 31 Dec 2023
Q3 2023 -65065% -3005% -4.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -62910% +3170% +4.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -62612% -20586% -49% 01 Jan 2023 31 Mar 2023
Q4 2022 -146374% -111012% -314% 01 Oct 2022 31 Dec 2022
Q3 2022 -62060% -12167% -24% 01 Jul 2022 30 Sep 2022
Q2 2022 -66080% -24706% -60% 01 Apr 2022 30 Jun 2022
Q1 2022 -42026% -10708% -34% 01 Jan 2022 31 Mar 2022
Q4 2021 -35362% -11509% -48% 01 Oct 2021 31 Dec 2021
Q3 2021 -49892% -27605% -124% 01 Jul 2021 30 Sep 2021
Q2 2021 -41374% -22115% -115% 01 Apr 2021 30 Jun 2021
Q1 2021 -31318% +11133% +26% 01 Jan 2021 31 Mar 2021
Q4 2020 -23853% +133838% +85% 01 Oct 2020 31 Dec 2020
Q3 2020 -22287% +147018% +87% 01 Jul 2020 30 Sep 2020
Q2 2020 -19259% +109837% +85% 01 Apr 2020 30 Jun 2020
Q1 2020 -42450% +145720% +77% 01 Jan 2020 31 Mar 2020
Q4 2019 -157691% +51648% +25% 01 Oct 2019 31 Dec 2019
Q3 2019 -169305% +34664% +17% 01 Jul 2019 30 Sep 2019
Q2 2019 -129097% +237793% +65% 01 Apr 2019 30 Jun 2019
Q1 2019 -188170% +73214% +28% 01 Jan 2019 31 Mar 2019
Q4 2018 -209338% +10928% +5% 01 Oct 2018 31 Dec 2018
Q3 2018 -203969% +6390% +3% 01 Jul 2018 30 Sep 2018
Q2 2018 -366890% -156690% -75% 01 Apr 2018 30 Jun 2018
Q1 2018 -261385% -19860% -8.2% 01 Jan 2018 31 Mar 2018
Q4 2017 -220267% +62686% +22% 01 Oct 2017 31 Dec 2017
Q3 2017 -210360% +76927% +27% 01 Jul 2017 30 Sep 2017
Q2 2017 -210200% +122267% +37% 01 Apr 2017 30 Jun 2017
Q1 2017 -241524% -46122% -24% 01 Jan 2017 31 Mar 2017
Q4 2016 -282952% -181734% -180% 01 Oct 2016 31 Dec 2016
Q3 2016 -287287% -220959% -333% 01 Jul 2016 30 Sep 2016
Q2 2016 -332467% -294900% -785% 01 Apr 2016 30 Jun 2016
Q1 2016 -195402% -187645% -2419% 01 Jan 2016 31 Mar 2016
Q4 2015 -101219% -100349% -11538% 01 Oct 2015 31 Dec 2015
Q3 2015 -66328% 01 Jul 2015 30 Sep 2015
Q2 2015 -37567% 01 Apr 2015 30 Jun 2015
Q1 2015 -7758% 01 Jan 2015 31 Mar 2015
Q4 2014 -870% 01 Oct 2014 31 Dec 2014

ImmunityBio, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -2334% +55905% +96% 01 Jan 2024 31 Dec 2024
2023 -58240% +88135% +60% 01 Jan 2023 31 Dec 2023
2022 -146374% -111012% -314% 01 Jan 2022 31 Dec 2022
2021 -35362% +1147% +3.1% 01 Jan 2021 31 Dec 2021
2020 -36509% -29413% -415% 01 Jan 2020 31 Dec 2020
2019 -7096% +202242% +97% 01 Jan 2019 31 Dec 2019
2018 -209338% +10928% +5% 01 Jan 2018 31 Dec 2018
2017 -220267% +62688% +22% 01 Jan 2017 31 Dec 2017
2016 -282955% -181736% -180% 01 Jan 2016 31 Dec 2016
2015 -101219% -100349% -11538% 01 Jan 2015 31 Dec 2015
2014 -870% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.